Menopause
Early natural menopause increases risk for lung diseases, death in women who smoke
In midlife and older smokers, natural menopause before age 45 years was associated with malignant and nonmalignant lung diseases and mortality, according to data published in the American Journal of Obstetrics & Gynecology.
FDA accepts new drug application for fezolinetant
The FDA accepted a new drug application from Astellas for fezolinetant, a nonhormonal drug for treating moderate to severe menopause-related vasomotor symptoms, according to a company press release.
Daily prune consumption preserves, protects bones in postmenopausal women
In postmenopausal women, eating prunes every day prevented loss of hip bone mineral density and protected against hip fractures, according to a randomized controlled trial published in The American Journal of Clinical Nutrition.
Premature menopause associated with HF, AF risk
Women with a history of premature menopause, defined as menopause before age 40 years, are more likely to develop HF or atrial fibrillation over 9 years of follow-up compared with women without premature menopause, data show.
Study identifies variables associated with heart palpitations in menopause
Certain factors were associated with heart palpitations in menopause, according to findings of a scoping literature review in Women’s Health.
Female patients with RA receiving exogenous sex hormones more likely to achieve remission
Female patients with rheumatoid arthritis are more likely to achieve remission when treated with exogenous sex hormones, particularly those who are perimenopausal and early postmenopausal, according to data published in Rheumatology.
Top in endocrinology: Menopausal hormone therapy; bone turnover markers and mortality risk
The North American Menopause Society released an updated position statement confirming that the benefits of menopausal hormone therapy outweigh the risks for most women.
Updated position statement confirms menopausal HT benefits outweigh risks for most women
Menopausal hormone therapy remains the most effective treatment for vasomotor symptoms and genitourinary syndrome of menopause, according to an updated position statement from the North American Menopause Society.
White matter hyperintensity tied to menopause
Postmenopausal women had a greater burden of white matter hyperintensity — or WMH — compared with men and premenopausal women, as well as a faster increase in WMH, according to a cross-sectional analysis of the Rhineland Study.
VIDEO: Lundberg speaks on ischemia in women, CV effects of menopause hormone therapy
PHILADELPHIA — In this Healio video exclusive, Gina Lundberg, MD, FACC, provides an overview of the Heart in Diabetes CME conference presentation, titled “CVD in Women, Ischemia Diagnosis and Menopause Hormone Therapy.”